dpp-4 inhibitors

Joint pain with type 2 diabetes linked with DPP-4 inhibitor

Researchers uncovered that joint pain in people with type-2 diabetes is linked with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors. The FDA has made an announcement adding additional warnings to DPP-4 inhibitors, stating it can increase joint pain in users with type-2 diabetes. Although the FDA doesn’t suggest stopping use of DPP-4 inhibitors they do ...click here to read more